International Urology Cancer Summit shared a post on LinkedIn about a recent paper by
” ‘Role of Hb to RDW ratio in metastatic RCC patients treated with first-line immunotherapy combinations’ explores a promising prognostic factor to improve patient counselling and guide treatment decisions.
Well done to all the authors.
Advancing insights in metastatic renal cell carcinoma!”
Authors: Matilde Corianò, Alessandro Lazzarini, Michele Maffezzoli, Alessio Signori, Sebastiano Buti et al.
More posts featuring International Urology Cancer Summit.
